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Serum was obtained from 17 individuals within 48 hours (baseline immune status) and 3-4 weeks after HB or YJ sting. None had a prior systemic reaction or had received desensitization therapy specific IgG and IgM antibodies (Ab) to YJ venom and HB phospholipase A (PL-A) were measured by ELISA. Specific IgE (RAST) and total serum IgE (PRIST) were also measured. Of the individuals stung by HB (3), none had a physical reaction or measurable IgG, IgM or IgE specific Ab. Only one person developed an immune response: IgG Ab to HB-PL-A. Fourteen people were stung by YJ. One individual who had high baseline IgG, M and E Ab to YJ had a systemic reaction. Four individuals with preexisting IgM Ab (geo. X ' 310 ELISA units vs non-stung controls, 75.9 units, p<0.001) had a large local reaction. Two of these 4 also had preexisting IgG Ab; 3/4 further increased their serum IgG Ab to YJ venom 3 weeks post-sting (avg 4.3-fold). The IgM did not change. Nine people who had no physical reaction to YJ sting had no preexisting IgG or IgM Ab to YJ venom. The serum IgG Ab increased in 4/9 (avg 12.1-fold) 3 weeks post-sting. Only 1/9 had an increase in the serum IgM and IgE Ab to YJ. Elevated pre existing IgM and IgG Ab may predispose individuals to large local reactions. IgG and IgM specific immune responses to HB and YJ venoms can occur inindividuals following natural sting.
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DiGeorge Syndrome (DGS) consists of the association of CHD, immunodeficiency, and hypoparathyroidism. Since recent data suggest that DGS is more common than usually appreciated, we prospectively tested immune function during the first 3 months of life in 22 infants referred for evaluation of CHD and 7 agematched controls. CHD patients as a group had T-cell rosettes (TCR) lower (mean + SE = 48% Lt 5) than age-matched controls (64% 5 4) or older normals (71% + 2). Eight of the 22 CHD infants had TCR below 2 standard deviations from the mean for age-matched controls (<40%). Six of 21 CHD infants had low peak phytohemaglut inin (PHA) responses (<40,000 cpms) ; however the mean peak PHA response for CHD patients (78,000 cpms) was not different from age-matched controls (86,100 cpms) or older normals (98,000 cpms). All CHD patients had B-cell numbers comparable to controls (8-20%). When grouped by cardiac abnormality, 8 of 12 infants who had lesions previously described in DGS (interrupted aortic arch, aortic atresia/hypoplasia, truncus arteriosus, tetralogy of Fal lot, VSD), had low TCR or PHA, with 4 of the 8 having both low TCR and PHA. In contrast, 4 of 10 infants with CHD not associated with DGS had some evidence of immunodeficiency, with boarderline low TCR only in 3 of the 4.
These findings suggest that about 75% of patients with congenital heart disease, especially those with aortic arch abnormalities or truncus arteriosus, may have laboratory evidence indicative of depressed immune function. lmmunoregulatory cell function was tested prior to therapy in 3 children with systemic lupus (SLE) and 4 with mixed connective t Issue disease (MCTD). Diagnoses were made by the American Rheumatism Association's clinical criteria and elevated anti-DNA with low C3; Cq, and/or CHSO in SLE or elevated anti-ENA of RNP specificity in MCTD. Suppressor/helper function was evaluated by comparing pokeweed mitogen-induced lgG and IgM secretion in individual cultures of patients' lymphocytes (PELS) with that produced in co-cultures of PBLs of patients and normals. SLE patients produced more IgG (mean + S.E. = 10,100 + 6100 ng per 2 x 106 cells) in individual cultures than did 105 normals (1,450 + 2,100 ng); IgM production was similar in the two groups.
Co-cultures of SLE PELS with normals suggested normal immunoregulation in one patient, loss of suppressor function in one, and excess helper function in the other. Three of 4 MCTD patients produced normal amounts of lgG (3980 + 1780 ng) and normal immunoregulation was found in co-culture. One MCTD patient had markedly low IgG (220ng) and IgM (70ng) production and this patient excess suppressor function in co-culture.
Our results suggest that children with SLE may produce more lgG in response to pokeweed mitogen than normals and a variety of immunoregulatory abnormal it ies may be found in chi ldren with active, untreated autoimmune disease. Inhibition(LM1) a s a reliable in vitro assay o f a n t i g e n -s p e c i f i c a c t i v i t y in h u m a n l e u k o c y t e dialysates (D1.E) containing Transfer Factor. We have shown that treatment o f nonimmune leukocytes with snecific DL.E renders them immune to the antieen and DL.E treatment of immune leukocytes r e n d e r s them nonimrnunc to the antigens to which the DL.E donor was sensitive. These properties are designated"1nducer DL.EM (I-DLE) and "Suppressor DL.Etl(S-DLE) respectively (J.I.4/79).
Specific activity o f I-DL.E binds t o specific antigen-immunoabsorbent but not to specific antibody-immunoabsorbent (J.I.2/81).
We now suggest that I-DL.E AND S-DLE are separate moieties since 1 ) the antigen soecific activity in I-DLE binds to an affinity purified anti-VHantibody but not to anti-VL chain antibody(prepared by Civol) while S-D1.E binds to the anti-V, chain antibody;& 2) that S-DL.E does not bind antigen; preliminary results suggest that it binds IgG.
This suggests that antigen specific activity in I-DLE may represent a dialysable fragment of antigen binding sites o f immune T-cells; I-DL.E and S-DLE may be representative of a network system.
